Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Sells 2,000 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Alan J. Levy sold 2,000 shares of the company's stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the sale, the director now directly owns 25,319 shares of the company's stock, valued at $9,385,753.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Intuitive Surgical Stock Down 0.5 %

ISRG opened at $375.01 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The company has a market cap of $133.02 billion, a P/E ratio of 67.69, a price-to-earnings-growth ratio of 4.83 and a beta of 1.36. The firm's 50-day moving average price is $386.40 and its 200-day moving average price is $345.19.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company's revenue for the quarter was up 11.5% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 4.84 EPS for the current fiscal year.

Hedge Funds Weigh In On Intuitive Surgical


Never use this word on your phone (FBI could be watching)
This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...
Watch my unredacted video about what I think is coming next right here


Several hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $1,313,238,000. WCM Investment Management LLC acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $575,536,000. International Assets Investment Management LLC increased its holdings in Intuitive Surgical by 32,360.5% in the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider's stock worth $231,721,000 after buying an additional 684,749 shares during the period. Assenagon Asset Management S.A. increased its holdings in Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider's stock worth $513,056,000 after buying an additional 678,375 shares during the period. Finally, Alphinity Investment Management Pty Ltd increased its holdings in Intuitive Surgical by 113.2% in the 4th quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider's stock worth $430,525,000 after buying an additional 677,455 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on ISRG shares. Piper Sandler upped their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an "overweight" rating in a research note on Friday, April 19th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a research note on Friday, January 19th. Truist Financial upped their price objective on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a "buy" rating in a research note on Wednesday, January 24th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 24th. Finally, Raymond James increased their price target on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an "outperform" rating in a research report on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $396.17.

Check Out Our Latest Stock Analysis on ISRG

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Intuitive Surgical?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Intuitive Surgical and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles